Low relative abundances of the mucolytic bacterium Akkermansia muciniphila and Bifidobacterium spp. in feces of children with autism

Applied and Environmental Microbiology

Volumn 77, Issue 18, 2011, Pages 6718-6721

  Wang, Lv ^a   Christophersen, Claus T ^b   Sorich, Michael J ^a   Gerber, Jacobus P ^a   Angley, Manya T ^a   Conlon, Michael A ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

^b CSIRO   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BIFIDOBACTERIA; BIFIDOBACTERIUM; CHILDREN WITH AUTISMS; FECAL BACTERIA; MUCUS BARRIER; QUANTITATIVE REAL TIME PCR; RELATIVE ABUNDANCE;

DISEASES; POLYMERASE CHAIN REACTION;

BACTERIA;

BACTERIUM; CHILD HEALTH; FECES; GASTROENTERITIS; MENTAL HEALTH; POLYMERASE CHAIN REACTION; REAL TIME; RELATIVE ABUNDANCE;

ARTICLE; AUTISM; BACTERIAL LOAD; BIFIDOBACTERIUM; CHILD; DYSPEPSIA; FECES; GENETICS; HUMAN; ISOLATION AND PURIFICATION; METABOLISM; MICROBIOLOGY; MUCUS; REAL TIME POLYMERASE CHAIN REACTION; VERRUCOMICROBIA;

AUTISTIC DISORDER; BACTERIAL LOAD; BIFIDOBACTERIUM; CHILD; DYSPEPSIA; FECES; HUMANS; MUCUS; REAL-TIME POLYMERASE CHAIN REACTION; VERRUCOMICROBIA;

AKKERMANSIA MUCINIPHILA; BACTERIA (MICROORGANISMS); BIFIDOBACTERIUM;

EID: 80052799341     PISSN: 00992240     EISSN: 10985336     Source Type: Journal    
DOI: 10.1128/AEM.05212-11     Document Type: Article

References (29)

1. Adams, J. B., L. J. Johansen, L. D. Powell, D. Quig, and R. A. Rubin. 2011. Gastrointestinal flora and gastrointestinal status in children with autism-comparisons to typical children and correlation with autism severity. BMC Gastroenterol. 11:22.
2. Altieri, L., et al. 2011. Urinary p-cresol is elevated in small children with severe autism spectrum disorder. Biomarkers 16:252-260.
3. American Psychiatric Association. 2000. Diagnostic and statistical manual of mental disorders, 4th ed. American Psychiatric Press, Washington, DC.
4. Collado, C., M. Derrien, E. Isolauri, W. M. de Vos, and S. Salminen. 2007. Intestinal integrity and Akkermansia muciniphila, a mucin-degrading member of the intestinal microbiota present in infants, adults, and the elderly. Appl. Environ. Microbiol. 73:7767-7770.
5. Corazziari, E. S. 2009. Intestinal mucus barrier in normal and inflamed colon. J. Pediatr. Gastroenterol. Nutr. 48:S54-S55.
6. de Magistris, L., et al. 2010. Alterations of the intestinal barrier in patients with autism spectrum disorders and in their first-degree relatives. J. Pediatr. Gastr. Nutr. 51:418-424.
7. D'Eufemia, P., et al. 1996. Abnormal intestinal permeability in children with autism. Acta Paediatr. 85:1076-1079.
8. Finegold, S. M., et al. 2010. Pyrosequencing study of fecal microflora of autistic and control children. Anaerobe 16:444-453.
9. Finegold, S. M., et al. 2002. Gastrointestinal microflora studies in late-onset autism. Clin. Infect. Dis. 35:S6-S16.
10. Hellemans, J., G. Mortier, A. De Paepe, F. Speleman, and J. Vandesompele. 2007. qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol. 8:R19.
11. Horvath, K., J. C. Papadimitriou, A. Rabsztyn, C. Drachenberg, and J. Tyson Tildon. 1999. Gastrointestinal abnormalities in children with autistic disorder. J. Pediatr. 135:559-563.
12. MacFabe, D. F., et al. 2007. Neurobiological effects of intraventricular propionic acid in rats: possible role of short chain fatty acids on the pathogenesis and characteristics of autism spectrum disorders. Behav. Brain Res. 176:149-169.
13. MacFabe, D. F., et al. 2008. A novel rodent model of autism: intraventricular infusions of propionic acid increase locomotor activity and induce neuroinflammation and oxidative stress in discrete regions of adult rat brain. Am. J. Biochem. Biotechnol. 4:146-166.
14. Miller, R. S., and L. C. Hoskins. 1981. Mucin degradation in human colon ecosystems. Fecal population densities of mucin-degrading bacteria estimated by a "most probable number" method. Gastroenterology 81:759-765.
15. Park, A. J., et al. 2011. The anxiolytic effect of Bifidobacterium longum Ncc3001 requires vagal integrity for gut-brain communication. Gastroenterology 140:S18-S19.
16. Parracho, H. M., M. O. Bingham, G. R. Gibson, and A. L. McCartney. 2005. Differences between the gut microflora of children with autistic spectrum disorders and that of healthy children. J. Med. Microbiol. 54:987-991.
17. Parracho, H. M. R. T., et al. 2010. A double-blind, placebo-controlled, crossover-designed probiotic feeding study in children diagnosed with autistic spectrum disorders. Int. J. Probiotics Prebiotics 5:69-74.
18. Png, C. W., et al. 2010. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 105:2420-2428.
19. Sandler, R. H., et al. 2000. Short-term benefit from oral vancomycin treatment of regressive-onset autism. J. Child Neurol. 15:429-435.
20. Schopler, E., R. J. Reichler, R. F. DeVellis, and K. Daly. 1980. Toward objective classification of childhood autism: childhood autism rating scale (CARS). J. Autism Dev. Disord. 10:91-103.
21. Smith, R. A., H. Farnworth, B. Wright, and V. Allgar. 2009. Are there more bowel symptoms in children with autism compared to normal children and children with other developmental and neurological disorders? A case control study. Autism 13:343-355.
22. Song, Y., C. Liu, and S. M. Finegold. 2004. Real-time PCR quantitation of clostridia in feces of autistic children. Appl. Environ. Microbiol. 70:6459-6465.
23. Vandesompele, J., et al. 2002. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol. 3:RESEARCH0034.
24. Walker, A. W., S. H. Duncan, E. C. McWilliam Leitch, M. W. Child, and H. J. Flint. 2005. pH and peptide supply can radically alter bacterial populations and short-chain fatty acid ratios within microbial communities from the human colon. Appl. Environ. Microbiol. 71:3692-3700.
25. Wang, L., et al. 2010. Gut bacterial and fermentation profiles are altered in children with autism. J. Gastroenterol. Hepatol. 25(Suppl. 3):A116-A119.
26. Wang, L., et al. 2009. Is urinary indolyl-3-acryloylglycine a biomarker for autism with gastrointestinal symptoms? Biomarkers 14:596-603.
27. Wexler, H. M. 2007. Bacteroides: the good, the bad, and the nitty-gritty. Clin. Microbiol. Rev. 20:593-621.
28. Yap, I. K., et al. 2010. Urinary metabolic phenotyping differentiates children with autism, from their unaffected siblings and age-matched controls. J. Proteome Res. 9:2996-3004.
29. Yu, Z., and M. Morrison. 2004. Improved extraction of PCR-quality community DNA from digesta and fecal samples. Biotechniques 36:808-812.